FWA Webinar 2021
The Council for Medical Schemes (CMS) is proud to announce that the 2021 FWA Summit will take place in the form of an online webinar. The 2021 Fraud, Waste and Abuse Webinar aims at setting the scene for the establishment of Codes of Good Practice and Standards for
Graduate Internship Programme
The CMS is offering a Graduate Internship Programme for unemployed graduates between the ages of 18 and 35, who are in possession of an appropriate qualification in order to gain work-related experience. The following internship positions are available: Supply Chain Management Intern Human Resources Intern Risk
CMScript: Focus on Substance Use Disorders
How do medical schemes treat substance abuse and what is covered under PMB regulations? The PMB regulations include substance abuse and the use of drugs under the following Diagnostic Treatment Pairs (DTP): DTP Code DTP Description Treatment 182T Abuse or dependence on Psychoactive substance, including alcohol Hospital-based management up to 3 weeks/year 910T Acute
CMScript: Focus on Glaucoma
Glaucoma is a PMB condition, which means that all medical schemes are required by law to pay for the diagnosis, treatment, and care of glaucoma regardless of the member’s benefit option. Treatment and care of Glaucoma is explained in terms of the PMB Regulations. Glaucoma is
PMB definition guideline v7.5
This guideline seeks to clarify PMB entitlements of medical scheme beneficiaries within the context of the pandemic, ensuring that there is uniform interpretation amongst all stakeholders. It sets out recommendations for the vaccination, screening, diagnosis, treatment, and care of individuals with suspected, and confirmed COVID-19
Joint Press Statement by the CMS, BHF, HFA & Non-affiliated schemes
The Council for Medical Schemes (CMS), together with industry representative bodies the Board of Healthcare Funders (BHF), the Health Funders Association (HFA) and non-affiliated medical schemes (the Funders Working Group), have come together to support efforts to provide broader health coverage through effective management of
Section 59 Investigation Interim Report
The Section 59 Investigating Panel has concluded its investigation and publishes an interim Report for comment by close of business on Friday, 5 March 2021. Find the summary of the Section 59 Investigation here Find the full Section 59 Investigation Interim Report here Annexures to the report Racial Bias
Festive Closure
Please note that the Council for Medical Schemes will close from 24 December 2020 at 10:00 for the festive season. The office will re-open at 08:00 on 4 January 2021. We wish you and your families a blessed and safe festive season.
CMS Annual Report 2019/20
The Council for Medical Schemes (CMS) launched its 2019/20 Annual Report today, revealing a consoling view of the medical schemes industry which experienced a slight increase in the total number of medical scheme beneficiaries from 8.92 in 2018, to 8.95 million in 2019. Beneficiaries The CMS regulated
New Chairperson for CMS Council
Dr Memela Makiwane has been appointed the new Chairperson of the Council of CMS, together with 14 other members. Dr Makiwane is a qualified doctor specialising in clinical pharmacology, with extensive experience in the private and public healthcare. Dr Makiwane has held various medical and scientific